Global Historical Cash Flow

GLH Stock

0.14 0.01 7.69%

Analysis of Global Health cash flow over time is an excellent tool to project Global Health future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Depreciation of 5.6 K or Other Non Cash Items of 82.9 K as it is a great indicator of Global Health ability to facilitate future growth, repay debt on time or pay out dividends.

Cash Flow Balance Sheet Income Statement

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Global Health latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Global Health is a good buy for the upcoming year.

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Global Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Global Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in Global balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Global's non-liquid assets can be easily converted into cash.

Global Health Cash Flow Chart

At this time, Global Health's Other Cashflows From Financing Activities is comparatively stable compared to the past year. Stock Based Compensation is likely to gain to about 30.4 K in 2024, whereas Begin Period Cash Flow is likely to drop slightly above 1.7 M in 2024.

Begin Period Cash Flow Capital Expenditures End Period Cash Flow Stock Based Compensation Sale Purchase Of Stock

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.

Capital Expenditures

Capital Expenditures are funds used by Global Health to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Global Health operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.

Stock Based Compensation

Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.

Most accounts from Global Health's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Global Health current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Global Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Global Health cash flow statement Correlations

	Change In Cash	Free Cash Flow	Begin Period Cash Flow	Depreciation	Other Non Cash Items	Capital Expenditures	Net Income	End Period Cash Flow	Change To Inventory	Change To Account Receivables	Stock Based Compensation	Change In Working Capital	Net Borrowings	Change To Operating Activities	Change To Netincome	Change To Liabilities	Investments	Sale Purchase Of Stock	Issuance Of Capital Stock
Change In Cash		0.6	-0.52	0.13	-0.44	-0.08	0.64	0.47	0.28	0.19	0.16	-0.01	-0.1	0.14	-0.31	-0.39	0.18	0.7	0.71
Free Cash Flow	0.6		-0.74	-0.35	-0.43	-0.56	0.89	-0.17	0.0	0.04	0.11	-0.28	0.08	0.33	-0.44	-0.39	-0.32	0.04	0.05
Begin Period Cash Flow	-0.52	-0.74		0.32	0.67	0.41	-0.86	0.51	-0.05	-0.08	0.29	0.48	-0.09	0.17	0.45	0.3	0.22	0.13	0.1
Depreciation	0.13	-0.35	0.32		0.42	0.6	-0.4	0.46	0.44	-0.15	0.33	-0.03	-0.34	-0.07	0.03	-0.13	0.64	0.39	0.48
Other Non Cash Items	-0.44	-0.43	0.67	0.42		0.49	-0.74	0.24	-0.1	-0.08	0.14	0.13	-0.05	0.28	0.35	0.1	0.27	0.01	-0.05
Capital Expenditures	-0.08	-0.56	0.41	0.6	0.49		-0.52	0.33	-0.17	0.01	0.04	0.15	-0.39	-0.07	-0.1	0.22	0.69	0.31	0.43
Net Income	0.64	0.89	-0.86	-0.4	-0.74	-0.52		-0.24	-0.08	-0.07	-0.1	-0.42	0.07	0.07	-0.52	-0.33	-0.28	0.06	0.07
End Period Cash Flow	0.47	-0.17	0.51	0.46	0.24	0.33	-0.24		0.24	0.1	0.47	0.48	-0.2	0.32	0.17	-0.08	0.41	0.84	0.8
Change To Inventory	0.28	0.0	-0.05	0.44	-0.1	-0.17	-0.08	0.24		0.5	0.32	0.29	-0.16	0.02	0.12	-0.44	0.0	0.28	0.3
Change To Account Receivables	0.19	0.04	-0.08	-0.15	-0.08	0.01	-0.07	0.1	0.5		0.02	0.72	-0.15	0.15	-0.17	-0.28	-0.21	0.25	0.29
Stock Based Compensation	0.16	0.11	0.29	0.33	0.14	0.04	-0.1	0.47	0.32	0.02		0.38	-0.32	0.57	0.19	0.14	0.37	0.1	0.24
Change In Working Capital	-0.01	-0.28	0.48	-0.03	0.13	0.15	-0.42	0.48	0.29	0.72	0.38		-0.24	0.28	0.14	0.06	0.02	0.3	0.36
Net Borrowings	-0.1	0.08	-0.09	-0.34	-0.05	-0.39	0.07	-0.2	-0.16	-0.15	-0.32	-0.24		-0.45	-0.11	0.31	-0.61	-0.1	-0.2
Change To Operating Activities	0.14	0.33	0.17	-0.07	0.28	-0.07	0.07	0.32	0.02	0.15	0.57	0.28	-0.45		0.21	-0.31	0.1	0.08	0.04
Change To Netincome	-0.31	-0.44	0.45	0.03	0.35	-0.1	-0.52	0.17	0.12	-0.17	0.19	0.14	-0.11	0.21		0.05	0.19	-0.17	-0.35
Change To Liabilities	-0.39	-0.39	0.3	-0.13	0.1	0.22	-0.33	-0.08	-0.44	-0.28	0.14	0.06	0.31	-0.31	0.05		0.25	-0.35	-0.21
Investments	0.18	-0.32	0.22	0.64	0.27	0.69	-0.28	0.41	0.0	-0.21	0.37	0.02	-0.61	0.1	0.19	0.25		0.21	0.34
Sale Purchase Of Stock	0.7	0.04	0.13	0.39	0.01	0.31	0.06	0.84	0.28	0.25	0.1	0.3	-0.1	0.08	-0.17	-0.35	0.21		0.94
Issuance Of Capital Stock	0.71	0.05	0.1	0.48	-0.05	0.43	0.07	0.8	0.3	0.29	0.24	0.36	-0.2	0.04	-0.35	-0.21	0.34	0.94

Click cells to compare fundamentals

Global Health Account Relationship Matchups

Global Health cash flow statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Change In Cash	(137.7K)	4.2M	1.5M	(4.1M)	(177.8K)	(168.9K)
Free Cash Flow	(839.9K)	675.2K	(2.1M)	(4.4M)	(1.2M)	(1.1M)
Begin Period Cash Flow	804.0K	666.3K	4.8M	6.4M	2.2M	1.7M
Other Cashflows From Financing Activities	(219.8K)	(441.6K)	156.5K	(735.0)	982.6K	1.0M
Depreciation	621.3K	620.9K	287.8K	487.7K	5.9K	5.6K
Other Non Cash Items	35.6K	1.0M	693.6K	4.6M	87.2K	82.9K
Capital Expenditures	698.9K	695.3K	895.5K	893.5K	17.5K	16.6K
Net Income	(200.1K)	(488.0K)	(2.0M)	(8.1M)	(1.3M)	(1.2M)
Total Cash From Financing Activities	256.1K	3.2M	3.5M	240.9K	982.6K	638.4K
End Period Cash Flow	666.3K	4.8M	6.4M	2.2M	2.1M	1.8M
Total Cash From Operating Activities	(141.0K)	1.4M	(1.2M)	(3.5M)	(1.1M)	(1.1M)
Change To Inventory	(203.4K)	339.9K	(517.7K)	(333.9K)	(300.6K)	(315.6K)
Change To Account Receivables	(791.9K)	658.4K	30.5K	(132.8K)	(161.8K)	(153.7K)
Stock Based Compensation	32.7K	34.7K	30.5K	18.6K	21.4K	30.4K
Change In Working Capital	(588.5K)	318.5K	548.2K	201.2K	86.2K	90.5K
Net Borrowings	(678.8K)	(515.9K)	(162.4K)	(97.5K)	(87.8K)	(83.4K)
Total Cashflows From Investing Activities	(252.8K)	(428.7K)	(778.9K)	(902.8K)	(1.0M)	(1.1M)
Change To Operating Activities	(58.3K)	44.4K	139.4K	87.6K	100.8K	71.9K
Change To Netincome	59.0K	1.1M	30.5K	3.9M	4.5M	4.7M
Change To Liabilities	187.0K	(521.8K)	378.3K	246.3K	283.3K	247.6K
Other Cashflows From Investing Activities	446.1K	266.6K	116.5K	(9.3K)	(8.4K)	(8.0K)
Investments	(252.8K)	(428.7K)	(778.9K)	(902.8K)	(1.0M)	(1.1M)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Global Stock Analysis

When running Global Health's price analysis, check to measure Global Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Global Health is operating at the current time. Most of Global Health's value examination focuses on studying past and present price action to predict the probability of Global Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Global Health's price. Additionally, you may evaluate how the addition of Global Health to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC